Sequence information
Variant position: 177 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 671 The length of the canonical sequence.
Location on the sequence:
LCTMGPGKVFGELAILYNCT
R TATVKTLVNVKLWAIDRQCF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LCTMGPGKVFGELAILYNCTR TATVKTLVN-VKLWAIDRQCF
Mouse LCTMGPGKVFGELAILYNCTR TATVKTLVN-VKLWAIDRQC
Bovine LCTMGPGKVFGELAILYNCTR TATVKTLVN-VKLWAIDRQC
Rabbit LCTMGPGKVFGELAILYNCTR TATVKTLVN-VKLWAIDRQC
Drosophila LDKMGAGKAFGELAILYNCTR TASIRVLSEAARVWVLDRRV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 671
cGMP-dependent protein kinase 1
Nucleotide binding
177 – 178
3',5'-cAMP 1
Nucleotide binding
177 – 178
3',5'-cGMP 1
Region
103 – 220
cGMP-binding, high affinity
Alternative sequence
16 – 297
Missing. In isoform 3.
Literature citations
Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.
Guo D.C.; Regalado E.; Casteel D.E.; Santos-Cortez R.L.; Gong L.; Kim J.J.; Dyack S.; Horne S.G.; Chang G.; Jondeau G.; Boileau C.; Coselli J.S.; Li Z.; Leal S.M.; Shendure J.; Rieder M.J.; Bamshad M.J.; Nickerson D.A.; Kim C.; Milewicz D.M.;
Am. J. Hum. Genet. 93:398-404(2013)
Cited for: VARIANT AAT8 GLN-177; VARIANTS PHE-474 AND ALA-666; CHARACTERIZATION OF VARIANT AAT8 GLN-177;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.